Changes in outcomes and factors associated with survival in melanoma patients with brain metastases.
Saved in:
| Title: | Changes in outcomes and factors associated with survival in melanoma patients with brain metastases. |
|---|---|
| Authors: | Hasanov M; Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Milton DR; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Davies AB; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Sirmans E; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Saberian C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Posada EL; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Opusunju S; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Gershenwald JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Torres-Cabala CA; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Burton EM; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Colen RR; Center for Artificial Intelligence Innovation in Medical Imaging, University of Pittsburg, Pittsburg, Pennsylvania, USA., Huse JT; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Glitza Oliva IC; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Chung C; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., McAleer MF; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., McGovern SL; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Yeboa DN; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kim BYS; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Prabhu SS; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., McCutcheon IE; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Weinberg JS; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Lang FF; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Tawbi HA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Li J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Haydu LE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Davies MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ferguson SD; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. |
| Source: | Neuro-oncology [Neuro Oncol] 2023 Jul 06; Vol. 25 (7), pp. 1310-1320. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1523-5866 |
|---|---|
| DOI: | 10.1093/neuonc/noac251 |
